S. Lindhorst

发表

Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy.

Rickey Miller, N. Banik, A. Varma, 2015, Anticancer research.

High Levels of Gadolinium Deposition in the Skin of a Patient With Normal Renal Function

K. Maravilla, B. Thiers, W. C. Davis, 2016, Investigative radiology.

Seizures in Patients With Metastatic Brain Tumors: Prevalence, Clinical Characteristics, and Features on EEG.

A. Olar, E. Kutluay, A. Lekoubou, 2019, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

Current Studies of Immunotherapy on Glioblastoma

Rickey Miller, N. Banik, A. Varma, 2014, Journal of neurology and neurosurgery.

Seizures in patents with primary central nervous system lymphoma: Prevalence and associated features

A. Olar, E. Kutluay, S. Ajinkya, 2019, Journal of the Neurological Sciences.

ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA

M. Mehta, J. Villano, J. Raizer, 2019, Neuro-Oncology.

Medical management of chemotherapy-induced peripheral neuropathy: a concise review focusing on the past 5 years

S. Lindhorst, Rosa M. Michel Ortega, 2016 .

Mutation and Microsatellite Burden Predict Response to PD-1 Inhibition in Children with Germline DNA Replication Repair Deficiency

K. Cole, T. Pugh, C. Hawkins, 2021 .

An unusual presentation of chronic myelogenous leukemia: a review of isolated central nervous system relapse.

R. Lopez, S. Lindhorst, Ronald D Sanders, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Is pentoxifylline safe and effective in patients with amyotrophic lateral sclerosis?

M. Cudkowicz, S. Lindhorst, 2006, Nature Clinical Practice Neurology.

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

Arif N Ali, J. Villano, J. Raizer, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2022, JAMA oncology.

MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells

A. Varma, M. Alshareef, A. Das, 2020, Clinical and Translational Oncology.

Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth

A. Varma, M. Alshareef, A. Das, 2019, Clinical and Translational Oncology.

Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma

N. Banik, S. Lowe, A. Varma, 2018, Cancer Chemotherapy and Pharmacology.

DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells.

G. Getz, K. Cole, T. Kunkel, 2020, Cancer discovery.

A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathway

J. Jaboin, Rickey Miller, N. Banik, 2015, Tumor Biology.

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.

D. Merico, Z. Cohen, C. Hawkins, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comprehensive Analysis of Hypermutation in Human Cancer

K. Cole, P. Raman, C. Hawkins, 2017, Cell.

Adult Immuno-Oncology: Using Past Failures to Inform the Future.

M. Gilbert, D. Reardon, J. Harrison, 2020, Neuro-oncology.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2018, Journal of Translational Medicine.

Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency

Trevor J Pugh, K. Cole, T. Pugh, 2022, Nature Medicine.

Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns

David T. W. Jones, K. Cole, W. Mason, 2020, Acta Neuropathologica.

Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment

A. Varma, Arabinda Das, M. Alshareef, 2020, Journal of the Neurological Sciences.

Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency

Trevor J Pugh, K. Cole, T. Pugh, 2022, Nature medicine.

Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

W. Foulkes, C. Hawkins, G. Nicholas, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Life without mismatch repair

M. Stratton, P. Campbell, M. Gerstung, 2021, bioRxiv.

Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastoma

S. Schwartz, A. Cherniack, A. Dubuc, 2020, Neuro-oncology advances.

Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.

K. Cole, W. Foulkes, W. Mason, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma

N. Banik, A. Varma, Arabinda Das, 2015, Cancer growth and metastasis.

Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report

M. Mehta, J. Villano, J. Raizer, 2019, International Journal of Radiation Oncology*Biology*Physics.

Clinical characteristics, EEG findings and implications of status epilepticus in patients with brain metastases

A. Olar, E. Kutluay, A. Lekoubou, 2019, Journal of the Neurological Sciences.

Current Use and Limitations of Cultured High-Grade Meningioma Cells in Neuro-Oncological Research – In Response to: “Caution Using Meningioma Cell Lines as Tumor Models”

Arabinda Das, S. Lindhorst, D. Cachia, 2021, Cancer investigation.

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2018, Journal of Translational Medicine.

RIP1 and RIP3 complex regulates radiation-induced programmed necrosis in glioblastoma

N. Banik, A. Varma, Arabinda Das, 2016, Tumor Biology.

IMMU-13. Dual CTLA4/ PD-1 blockade improves survival for replication-repair deficient high-grade gliomas failing single agent PD-1 inhibition: An IRRDC study

B. Ertl-Wagner, W. Libionka, D. Stearns, 2022, Neuro-Oncology.

Case report: Awake craniotomy during pregnancy for resection of glioblastoma

N. Rowland, Sunil J. Patel, C. Voelkel-Johnson, 2022, Clinical Neurology and Neurosurgery.

Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations

A. Varma, M. Alshareef, A. Das, 2020, Clinical and Translational Oncology.

Establishing a standardized method for the effective intraoperative collection and biological preservation of brain tumor tissue samples using a novel tissue preservation system: A pilot study.

Arabinda Das, B. Frankel, Sunil J. Patel, 2022, World neurosurgery.

Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.

K. Cole, D. Gass, A. Shlien, 2024, The Lancet. Oncology.